大理药业
(603963)
| 流通市值：17.80亿 | | | 总市值：17.80亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 39,680,747.92 | 14,193,988.72 | 16,565,530.88 | 99,613,730.79 |
| 应收票据及应收账款 | 1,807,386.74 | 1,865,977.85 | 4,094,332.95 | 5,759,963.64 |
| 其中：应收票据 | - | 177,435 | 112,617 | 75,078 |
| 应收账款 | 1,807,386.74 | 1,688,542.85 | 3,981,715.95 | 5,684,885.64 |
| 预付款项 | 410,430.37 | 547,227 | 362,560 | 6,689,419 |
| 其他应收款合计 | 171,873.32 | 37,431.98 | 158,054.19 | 182,685.18 |
| 存货 | 61,029,039.1 | 63,842,014.2 | 48,899,090.73 | 27,163,077.42 |
| 其他流动资产 | 35,088.8 | 1,922,826.1 | 1,755,844.72 | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 278,867,887.21 | 289,147,603.51 | 278,028,886.44 | 275,579,769.02 |
| 非流动资产: | | | | |
| 投资性房地产 | 61,389,554.42 | 61,845,147.89 | 62,300,741.36 | 62,756,333.58 |
| 固定资产 | 79,073,452.66 | 79,239,236.75 | 76,233,882.47 | 77,300,281.03 |
| 在建工程 | 682,886 | 1,824,526 | 4,794,603.43 | 5,364,585.7 |
| 使用权资产 | 1,692,275.25 | 1,895,348.28 | 2,097,291.9 | 2,307,021.09 |
| 无形资产 | 34,684,858.18 | 34,953,178.33 | 35,221,498.48 | 35,393,174.08 |
| 递延所得税资产 | 4,936,774.01 | 4,865,670.86 | 5,612,092.88 | 5,676,618.09 |
| 其他非流动资产 | 9,100 | 63,100 | 622,800 | 1,625,728.8 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 182,468,900.52 | 184,686,208.11 | 186,882,910.52 | 190,423,742.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 461,336,787.73 | 473,833,811.62 | 464,911,796.96 | 466,003,511.39 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 10,036,869.56 | 10,191,156.32 | 9,209,742.89 | 9,662,367.8 |
| 应付账款 | 10,036,869.56 | 10,191,156.32 | 9,209,742.89 | 9,662,367.8 |
| 预收款项 | 643,909.58 | 169,362.66 | 390,446.17 | 366,972.47 |
| 合同负债 | 13,802,990.06 | 19,266,616.96 | 1,044,350.29 | 1,302,331.89 |
| 应付职工薪酬 | 836,972.81 | 836,972.81 | 815,628.53 | 850,993.71 |
| 应交税费 | 820,992.47 | 2,960,216.23 | 803,557.24 | 887,896.68 |
| 其他应付款合计 | 35,034,341.26 | 34,669,848.19 | 33,009,143.24 | 28,682,998.66 |
| 一年内到期的非流动负债 | 8,827,197.51 | 8,813,051.79 | 17,105,921.42 | 12,707,284.81 |
| 其他流动负债 | 43,276.29 | 60,595.14 | 73,675.93 | 44,871.38 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 70,046,549.54 | 76,967,820.1 | 62,452,465.71 | 54,505,717.4 |
| 非流动负债: | | | | |
| 长期借款 | 14,020,339.26 | 14,017,887.5 | 14,533,907.5 | 18,521,872.5 |
| 租赁负债 | 831,595.96 | 831,595.96 | 1,295,920.58 | 1,689,729.46 |
| 递延收益 | 324,500.21 | 346,500.2 | 368,500.19 | 390,500.18 |
| 递延所得税负债 | 363,839.43 | 545,022.9 | 493,614.74 | 521,687.2 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 15,540,274.86 | 15,741,006.56 | 16,691,943.01 | 21,123,789.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 85,586,824.4 | 92,708,826.66 | 79,144,408.72 | 75,629,506.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 219,700,000 | 219,700,000 | 219,700,000 | 219,700,000 |
| 资本公积 | 117,799,200 | 117,799,200 | 117,799,200 | 117,799,200 |
| 盈余公积 | 32,668,913.13 | 32,668,913.13 | 32,668,913.13 | 32,668,913.13 |
| 未分配利润 | 5,581,850.2 | 10,956,871.83 | 15,599,275.11 | 20,205,891.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 375,749,963.33 | 381,124,984.96 | 385,767,388.24 | 390,374,004.65 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 375,749,963.33 | 381,124,984.96 | 385,767,388.24 | 390,374,004.65 |
| 负债和股东权益合计 | 461,336,787.73 | 473,833,811.62 | 464,911,796.96 | 466,003,511.39 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |